INmune Bio, Inc. (NASDAQ:INMB) Q3 2025 Earnings Call Transcript October 30, 2025
INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.24, expectations were $-0.31.
Operator: “
Daniel Carlson: “
David Moss: “
Mark Lowdell: “
CJ Barnum: “
Cory Ellspermann: “
Denis Reznik: ” Raymond James Ltd., Research Division
Jason Mccarthy: ” Maxim Group LLC, Research Division
Unknown Analyst: “
Operator: Greetings, and welcome to the INmune Bio Third Quarter 2025 Earnings Call. [Operator...
